Multi-Year Multi-Indication Agreements for Supporting Patient Access to Oncology Medicines with Multiple Indications: An Experimental Approach or Here to Stay?
Over the past decade, an increasing number of oncology medicines with indications for multiple cancer types have been delivering benefits to patients. To ensure these products reach patients, pricing and reimbursement systems have had to adapt to address the value assessment, time-to-access, afforda...
Saved in:
| Main Authors: | Hannah Armstrong, Angelina Petrova, Tim Wilsdon, Henriette Homoki, Alexander Roediger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Journal of Market Access & Health Policy |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2001-6689/13/1/2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Accelerating patient access to oncology medicines with multiple indications in Europe
by: R. Lawlor, et al.
Published: (2021-01-01) -
Insights from veterinary models for advancing oncolytic virotherapy through comparative oncology
by: Almohanad A. Alkayyal
Published: (2025-05-01) -
A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity
by: Diana I. Albu, et al.
Published: (2024-12-01) -
Oncobiomics: Leveraging Microbiome Translational Research in Immuno-Oncology for Clinical-Practice Changes
by: Carolina Alves Costa Silva, et al.
Published: (2025-03-01) -
Non-[<sup>18</sup>F]FDG PET-Radiopharmaceuticals in Oncology
by: Antonia Dimitrakopoulou-Strauss, et al.
Published: (2024-12-01)